Patent · US Active

Apparatus and method for in-vivo plasmapheresis using periodic backflush containing anticoagulant

US7476210B2 · kind B2 · utility

6Cited by
30References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 29, 2005
Grant dateJan 13, 2009
Priority date
Expiry dateJan 6, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2025/0037
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Method for in-vivo plasmapheresis utilizing a plurality of elongated hollow microporous filter fibers periodically interrupt diffusion of blood plasma from a patient, and, for a selected time, directing backflush fluid into the fibers at a pressure and interval sufficient to cleanse the fiber pores, after which plasma diffusion is resumed. The backflush fluid, preferably a normal saline solution, may contain an anticoagulant such as heparin, citrate or NO donor in suitable concentration for systemic anti-coagulation or for treating the fiber for thromboresistance.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.